iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. NVDA
8. ULTA
9. GAP
10. DG

Go back to iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.36 --0 (-0%)
Previous Close $1.36    52 Week High $0.80 
Open $1.36    52 Week Low $0.34 
Day High $1.36    P/E N/A 
Day Low $1.36    EPS $-0.08 
Volume 51       

IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.36 --0 (-0%)
Previous Close $1.36    52 Week High $0.80 
Open $1.36    52 Week Low $0.34 
Day High $1.36    P/E N/A 
Day Low $1.36    EPS $-0.08 
Volume 51